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Abstract
We report the appearance of a Mycoplasma haemocanis
infection in laboratory dogs, which has been reported
previously, yet, never before in Europe. Outbreak of the
disease was triggered by a splenectomy intended to pre-
pare the dogs for a hemorrhagic shock study. The clinical
course of the dogs was dramatic including anorexia and
hemolytic anemia. Treatment included allogeneic trans-
fusion, prednisone, and oxytetracycline. Systematic fol-
low-up (n = 12, blood smears, antibody testing and spe-
cific polymerase chain reaction) gives clear evidence that
persistent eradication of M. haemocanis is unlikely. We,
therefore, had to abandon the intended shock study. In
the absence of effective surveillance and screening for
M. haemocanis, the question arises whether it is prudent
to continue shock research in splenectomized dogs.
Copyright © 2004 S. Karger AG, Basel
Introduction
Pathophysiology and therapy of hemorrhagic shock
is – and will remain – a core field of interest in surgical
research. In vivo models are performed in small rodents,
but also in large mammalians. The latter remains indis-
pensable, since investigation of O2 transport, regional
peripheral perfusion and tissue oxygenation requires ex-
tensive surgical instrumentation and sufficient dimen-
sions of the organs of interest. Traditionally, dogs are the
preferred animals in the design of experimental hemor-
rhagic shock models. Efforts to standardize the experi-
mental shock insult included control of volume depletion
[1], control of blood pressure reduction [2], and control of
accumulated O2 debt [3, 4].
However, investigators are still confronted with con-
siderable variability in the canine cardiovascular shock
response, since the canine spleen acts as a blood reservoir
and contracts during hemorrhage, expelling red cells, thus
increasing hematocrit, circulating blood volume, left ven-
tricular preload, cardiac output and arterial O2 content
[5–7], which dramatically enhances the canine cardiovas-
cular stress response [6, 8]. Canine splenic contraction is
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mediated by endothelin and by norepinephrine via ·1-
adrenoceptors [9]. Of note, the splenic release of red cells
is variable in dogs and negligible in humans [5]. There-
fore, to allow extrapolation of results from canine experi-
ments to the human setting, splenectomy prior to induc-
tion of hemorrhagic shock is a frequently used procedure.
In 1975, Pryor and Bradbury [10] published a systematic
report on 20 splenectomized beagle dogs from the US
Naval Medical Field Research Laboratory and Medical
Research Center suffering from a parasitemic disease that
caused anemia.
Mycoplasma haemocanis (formerly Haemobartonella
canis) is well known to veterinary physicians all over the
world [11–13]. It is assumed that infection of dogs with
M. haemocanis is not an unusual event. However, clinical
outbreak of the disease requires previous immunosup-
pression, coexistent infection, or, most importantly,
splenectomy [14–16]. The disease was infrequently recog-
nized and thought to be of limited relevance in research –
an epidemic outbreak in a European research institution
has not been reported until today. We describe an impres-
sive episode of epidemic M. haemocanis infection in our
laboratory, complicating a large experimental study. We
had to terminate our project prematurely, fearing that this
infection would be a confounding factor when analyzing
the experimental results. The question arises whether it is
prudent to go on conducting research involving the use of
splenectomized dogs in the future.
Methods
Design
The purpose-bred dogs were purchased from an established com-
mercial breeder in Germany to be included in a hemorrhagic shock
study. For prophylaxis against ectoparasites, fenthion 200 mg (Bayer,
Leverkusen, Germany) was administered externally at the time of
admission to our laboratory. Subsequently, the animals were allowed
to recover from transportation for 48 h, and underwent routine splen-
ectomy afterwards. Triggered by this procedure, overt disease with M.
haemocanis was observed, diagnosed and treated as documented
below (case report, n = 2). In an attempt to continue the planned
project, we purchased 12 additional dogs from the same breeder. To
identify whether a potential contact with M. haemocanis might have
occurred prior to arrival at our institution, we took samples of whole
blood and serum, including blood smears from all dogs within the 1st
h after arrival. Animals were splenectomized. M. haemocanis was
detected. Treatment was initiated and systematic follow-up was per-
formed (prospective follow-up over 120 days; n = 12).
Splenectomy, Postoperative Care
Following overnight starvation, splenectomy was performed un-
der aseptic conditions under general anesthesia (propofol, fentanyl)
and antibiotic prophylaxis (cefuroxim 750 mg), followed by daily
clinical evaluations of the dogs. All animals recovered in relation to
their preoperative condition. There were no postoperative events of
bleeding, suture dehiscence, peritonitis, ileus or wound infection.
After at least 6 weeks of recovery the animals were to undergo the
planned hemorrhagic shock experiment. This stepwise experimental
procedure has been routinely performed by our group for several
years [17].
Detection of Anti-M. haemocanis Antibodies
To give indirect evidence for the presence of M. haemocanis, we
obtained serum samples, which were submitted for serologic testing.
Since M. haemocanis cross-reacts with Rickettsia conori, sera were
subjected to the indirect fluorescent antibody test in which R. conori
was used as antigen (Rickettsia conori-Spot IF, bioMerieux, Lyon,
France). FITC-labeled goat anti-dog IgM antibody and FITC-labeled
goat anti-dog IgG antibody (KPL, Gaithersburg, Md., USA) were
used to detect the presence of dog anti-M. haemocanis IgM and IgG
antibodies in the dog sera using a fluorescence microscope.
Specific Polymerase Chain Reaction Assay
Identification of the microorganism was performed using stan-
dard polymerase chain reaction (PCR) testing. DNA was extracted
from 2 ml of whole blood by a standard proteinase K treatment. The
technique has recently been described as being able to give evidence
of the presence of M. haemocanis (formerly H. canis) in dogs [18] and
Mycoplasma haemofelis in cats [19, 20] using a specific representa-
tive gene sequence that is largely congruent with minor variations for
both subspecies [21]. We chose a segment of 677 bp out of the 16S
rRNA gene to identify the parasite. Referring primers were generated
based on a BLAST genomic database search [22] at the National
Library of Medicine (http://www.ncbi.nlm.nih.gov), National Center
of Biotechnological Information.
To verify our method and diagnosis, we divided our blood sam-
ples and sent 8 whole blood samples for cross-checking to Prof. Dr. J.
Messick (VMD, University of Illinois, Urbana-Champaign, Ill.,
USA), who performed simultaneous PCR. Additional cross-checking
was made by a 3rd investigator (Prof. Dr. S. Shaw, Dr. S. Tasker,
Acarus Unit, Department of Clinical Veterinary Science, University
of Bristol, UK).
Data Analysis, Statistics
Data are presented as single observations over time in dogs 1279
and 1295. Data taken from the newly purchased and prospectively
investigated group (n = 12) are depicted as means and standard
deviations. Differences of measured values over time were analyzed
with a repeated measurements ANOVA (SAS-SystemTM, Cary, N.Y.,
USA). The ·-error threshold was set to 5%.
Results
Case Report
On day 49 after splenectomy, one dog (No. 1279) pre-
sented with apathy, inappetence, and a grossly reduced
physical condition. Our institutional veterinary con-
sultant found pale conjunctivae, cachexia, and fever
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(39.8°C) with no obvious external bleeding. At that time,
the hemoglobin concentration was 3.8 g dl–1 (day 49,
repeated measurements). Several weeks later, dog 1295, a
littermate of the previous dog, displayed very similar clin-
ical symptoms and blood analysis revealed a hemoglobin
concentration of 6.1 g dl–1 (day 133; table 1).
While abdominal sonography and chest X-ray dis-
played no pathological findings in dog 1279, the peripheral
blood count showed profound anemia including a promi-
nent left shift of white blood cell distribution (table 1). A
bone marrow biopsy showed reduced cellularity with a
pronounced increase in erythropoiesis (65%) and, to some
extent, in lymphopoiesis (20%). Granulopoiesis was dis-
placed (15%) and megakaryopoiesis was undetectable
(0%). Giemsa-stained blood smears of both dogs showed
anisocytosis, poikilocytosis, hypochromasia, Jolly bodies,
and basophilic or polychromatophilic epierythrocytic and
erythrocytic inclusion bodies, which were later identified
as resembling M. haemocanis (fig. 1). Due to a diagnosis of
life-threatening anemia, dog 1279 immediately received
200 ml packed allogeneic red cells (centrifuged at 4,000 g
over 10 min) pooled from the seemingly healthy litter-
mates as a single transfusion; methylprednisolone 100 mg
was given intravenously to prevent transfusion reactions.
Prednisone 2 mg kg–1 daily was continued orally for 4 days
to terminate para-infectious hemolytic anemia, and was
then tapered off over a period of 10 days. Dog 1295 was
treated with oxytetracycline and prednisone alone. Oxyte-
tracycline 40 mg kg–1 daily was given over a period of at
least 42 days in all animals. After that time, dogs 1279 and
1295 became vital with no clinical signs of acute anemia or
Fig. 1. Blood smears of dogs 1279 (A) and 1295 (B) at different
points in time. Small basophilic inclusion bodies are seen on the red
blood cells. Sometimes the inclusions were coccoid; however, chains
of organisms also split to produce Y-shaped and bow forms on the
red cell surface.







Postoperative day 49 133 119 140 196 196
Hemoglobin concentration, g dl–1 3.8 6.1 14.1 8.6 14.0 13.5
Platelet count, !109 l–1 74 1,130 24 955 426 442
White blood cell count, !109 l–1 23.9 27.4 8.2 8.4 16.4 13.7
Juveniles, % 21 9 4 – 1 2
Segmented, % 41 66 37 44 68 80
Eosinophilic, % 1 5 – 16 2 3
Basophilic, % – – – – – –
Monocytes, % 3 2 3 4 3 1
Lymphocytes, % 29 18 56 36 26 14
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Fig. 2. Changes in hemoglobin concentration (A), white blood cell
count (B), platelet count (C), body temperature and blood smear sta-
tus (D), and number of white cell subspecies in the hemogram (lym-
phocytes, E; monocytes, eosinophilics, F) over time. Twelve dogs
were followed up over a period of 120 days postoperatively. Data
are depicted as mean values. The error bars indicate the standard
deviation. Significant changes over time (repeated measurements
ANOVA; p ! 0.05) are indicated. With the initial marked increase in
white cell count treatment was commenced stepwise in all dogs.
Prednisone 2 mg kg–1 day–1 was given for 4 days; oxytetracycline
40 mg kg–1 day–1 was terminated in all dogs on day 98. Of note,
cyclic changes in white blood cell and platelet count persisted. How-
ever, there was no episode of anemia.
infection, and were included in the planned study. Hemo-
grams (table 1) and standard O2 transport parameters were
all within reference values at that time.
Systematic Postoperative Follow-Up
All 12 animals were deemed healthy on arrival and
underwent splenectomy without adverse events. On the
1st postoperative day, we noticed marked leukocytosis
(38 ! 109 l–1) and left shift (15% juveniles) accompanied
by a temporary drop in hemoglobin concentration by
3 g dl–1. On day 21, a second peak in white blood cell
count and a reduction in platelet count became evident
together with a rise in rectal temperature to 38.8°C (fig. 2)
and a marked increase in lymphocyte count. We observed
M. haemocanis-positive blood smears on day 21 (4/12)
and 35 (7/12), and significant antibody titers on day 35
(12/12). Treatment was commenced and maintained until
day 98. At approximately day 70 another peak in white
blood cell count became evident in the presence of critical
thrombocytopenia and slight eosinophilia (fig. 2). Blood
smears still remained positive for M. haemocanis (7/12),
despite prolonged antimicrobial therapy (fig. 3).
On day 119, blood smears (3/12), serum antibody sta-
tus (7/12) and specific PCR testing (8/12) were still posi-
tive for M. haemocanis (fig. 4).
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Fig. 3. Chosen blood smears from individual dogs at different points
in time. Small basophilic inclusion bodies in rods and doughnut
forms are seen, as well as single inclusion bodies. In 3 animals blood
smears remained positive for M. haemocanis despite antimicrobial
therapy over 42 days.
The latter was confirmed in a second PCR (University
of Illinois; 7/12); all 7 positive results were confirmed by
cloning of almost the entire 16S rRNA gene and subse-
quent sequence analysis, and by a third PCR (AY 150989
and AY 150988) [23].
Time of Infection
Eight of the 12 serum samples that had been taken
within the 1st h after animal arrival at our facility were
lost during overseas transport. In 2 of the remaining 4 ani-
mal serum specimens, significant titers of antibodies of
the IgM type cross-reactive for M. haemocanis were
detected in the absence of clinical disease (fig. 4).
Termination of Experimental Project
After confirmation of the diagnosis by 3 distinct labo-
ratories and at the time when persistence of M. haemo-
canis was evidenced despite completed antimicrobial
therapy, the institutional board for animal protection and
the Bavarian Government were informed and the experi-
mental series was terminated.
Discussion
Diagnosis of the Disease
Historically, the diagnosis of M. haemocanis relies on
smears of peripheral blood, in which M. haemocanis
mostly appears in coccoid form (0.2–0.4 Ìm), as rings,
doughnut forms, or rods [24, 25], but also as streptococ-
cal-like chains or bows [24, 26]. M. haemocanis is typical-
ly located in the deeply indented folds of the erythrocyte
surface. The parasite is Gram-negative and can be visual-
ized by classic Giemsa staining. Serologic testing for anti-
M. haemocanis cross-reactive antibodies may be helpful.
However, today the superior technique for obtaining un-
equivocal evidence of the presence of M. haemocanis is
PCR of whole blood [18–20].
Mode of Transmission
It is generally accepted that M. haemocanis is transmit-
ted by blood-feeding arthropods, especially the dog tick,
Rhipicephalus sanguineus [12, 13]. It may, however, be
transmitted by oral ingestion or directly penetrating blood
inoculation [12, 13]. There is also evidence for a possible
materno-fetal transplacental transmission [27].
Appearance of Clinical Disease
In principle, the disease may occur in two forms: a
latent form, which may be almost void of symptoms, and
an acute form, the clinical appearance of which has been
reviewed in detail [13, 15] and is documented in our case
report. Symptoms may occur quickly (1–2 weeks) [10, 26]
or, as in this case, with a delay (4–9 weeks) [18, 28].
Like others, we observed severe anemia, leukopenia
[29, 30], and also leukocytosis [15, 28] together with an
initial temporary left shift of white blood cell distribution
and delayed lymphocytosis [14, 30]. A reduced platelet
count is a frequent observation in dogs bearing M. haemo-
canis and may be associated with bleeding disorders [15,
28].
Pathophysiological Consequences of Infection
To date, it is not clear what damage is done to red cells
that are infected with M. haemocanis. Growth of the
microorganism seems possible without destruction of the
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Fig. 4. An overview of the consecutive results from serologic testing
and PCRs undertaken in the perioperative period. Serologic testing
for M. haemocanis cross-reactive antibodies was performed on blood
samples that had been withdrawn instantly on arrival from the breed-
er – prior to admission and hospitalization. Further testing was per-
formed on days 35 and 119 postoperatively, whereas PCR was per-
formed at the last point in time only. The right panel depicts a 1%
agarose gel stained with ethidium bromide. The specific signal gives a
fragment of 677 bp according to the sequence information (http://
www.ncbi.nlm.nih.gov, AF 407208). Serologic and PCR data are
plotted on days 1, 35, and 119 (from left to right), to enable direct
comparison of results obtained with the different methods. Serologic
evidence of contact with M. haemocanis was present in these dogs at
the time of admission. Over the time course, all animals showed evi-
dence of M. haemocanis infection either by light microscopy, sero-
logic testing, or the presence of specific DNA. 924, 784, 822, 823,
848, 851, 881, 882, 959, 998, 1084 and 1159 are the animal identifi-
cation numbers in the left panel, as well as in the right panel. M =
Molecular weight markers; + = positive control; Ø = negative control
in a healthy pet dog.
erythrocyte membrane. However, the cyclic nature of the
disease and apparent episodes of severe anemia suggest
the possibility that red cells might simply be destroyed by
the adhering microorganism at a critical point without
phagocytosis, or perhaps there is hemolysis by isoagglu-
tinines [24]. It is undeniable, however, that M. haemoca-
nis severely alters the shape and deformability of affected
red cells and causes anemia. It is obvious that this may
interfere with tissue perfusion and oxygen unloading at
the microcirculatory level.
Predisposition
The prevalence of M. haemocanis in the canine popu-
lation remains to be determined [13]. In the laboratory
setting it might be difficult to prevent the occurrence of
M. haemocanis, since infection occurs predominantly in
immunosuppressed and splenectomized dogs [13–15]. As
has been tested by our group in animals from different
kennels (unpublished data), and as reported herein, ken-
nel-raised dogs may have a higher prevalence of infection
than other dog populations [13]. This speculation needs to
be investigated further.
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Therapy
The therapy of choice is oxytetracycline at 20–40 mg
kg body weight, or doxycycline 5–10 mg kg body weight/
day [13, 15]. Administration of prednisone aims to limit
hemolysis and erythrocyte phagocytosis. It should be
restricted to several days and tapered off when hemoglo-
bin levels start to rise [13]. Of note, systemic antimicro-
bial therapy may not necessarily fully eliminate M. hae-
mocanis from the blood [15], as confirmed by our present
results (PCR, blood smears). A relapse may occur as late
as 6 months after infection [28]. Splenectomy may con-
tribute to the difficulties in eradication. In summary, the
course of the disease is largely unpredictable.
Practical Implications
At present, researchers in the field do need to establish
efficacious surveillance and need to conclusively show the
absence of infection with M. haemocanis to ensure the
validity of scientific results in the future. A proposal to
reduce the prevalence of M. haemocanis in a research lab-
oratory should include repeated eradication of potential
vectors like the dog tick R. sanguineus, separate housing,
frequent blood sampling and evaluation of blood smears,
but most importantly, PCR testing. PCR is commercially
available from veterinary laboratories, though this may be
costly (F40 EUR). Since PCR primers can be identified
at the NCBI (see above) and can be purchased, an in-
house PCR test for M. haemocanis may be established in
any laboratory where a PCR cycler exists and expertise is
at hand. The time required for cycling and reading does
not exceed 6 h. Up to 96 tests might be run simultaneous-
ly, and costs for a single tests can be kept low (F2 EUR) as
compared to commercial laboratories.
However, the frequency and timing of PCR testing
needed to ensure detection of an infection in principle
remain to be determined since parasitemia is transient,
which may prevent the detection of M. haemocanis. At
present, there is a long way to go before a surveillance for
M. haemocanis can become operative in everyday rou-
tine. Therefore, it is the authors’ opinion that at present
the conduction of experimental studies in splenectomized
or potentially immunosuppressed dogs is, in general, not
recommended.
Conclusion
We report on the first clinical outbreak of M. haemo-
canis in a European surgical research laboratory. Success-
ful treatment is possible, however, full eradication of
M. haemocanis is difficult to achieve. Reports on the
cumulated outbreak of this disease in immunosuppressed
and splenectomized dogs are growing. In experimental
cardiovascular studies on dogs, splenectomy is a frequent-
ly used procedure which may uncover a chronic M. hae-
mocanis infection. Thus, particularly with regard to ani-
mal protection issues, we need to carefully consider
whether it is prudent to continue performing experiments
in splenectomized or immunosuppressed dogs.
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